In the line of fire
India’s IP laws have been in the eye of a storm since it issued its first ever Compulsory Licence. Will they land us into the list…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Why are Indian generics under attack? One view from America
Giving a view from America, Roger Bate shares his impressions on the quality of generic drugs in India and opines that the CDSCO,…
Thomson Reuters names 2014 leading drugs to watch
Analysis points to three potential blockbusters: Sovaldi, Anoro Ellipta and Idelalisib entering market this year
Patent protection losses will hinder HIV treatment market growth within seven years: GBI Research
The first-line antiretroviral therapies Atripla and Truvada will lose patent protection during the forecast period, which will…
Waters Corporation launches NuGenesis Lab Management System
Powerful alternative to LIMS offers seamless lab-to-business connection for science-driven organisations
DTAB receives leadership in Animal Welfare Award
Recommended a ban on the import of cosmetics tested on animals as well as the manufacture and sale of oxytocin
Battling on Different Fronts
The pharma sector in Maharashtra is facing challenges from different quarters, including bureaucratic hurdles, unwarranted…
’Maharashtra is the hub of quality medicines’
Maharashtra still dominates the Indian pharma sector, emphasises Mahesh Zagade, Commissioner, FDA Maharashtra, in conversation…
Glenmark consolidated revenue increases by 27.53% to Rs. 17,035.60 million in Q4 FY 2013-14
EBITDA grew by 46.7 per cent to Rs 3816.17 millionGlenmark Pharmaceuticals announced its full year results for the year ended…
’Pharmaceuticals contribute 30 per cent to Ireland’s exports’
Ireland holds a formidable position on the global pharmaceutical map not only being home to nine out of ten pharma companies but…
Boehringer Ingelheim sees increase in operating income and return on net sales
Net sales of around €14.1 billion achieved
Lupin inks JV with Yoshindo
New entity YL Biologics to focus on clinical development and commercialisation of biosimilars for Japan
Suven Life secures product patents
Suven Life Sciences has received two patents, one product patent from Hong Kong (HK 1133002) and one product patent from Canada…
Piramal Enterprises, Merisant in pact
Signs exclusive sales and distribution partnership for Equal in India
Venus gets marketing nod from Venezuela for meropenem
Venus Remedies has extended its footprint in Latin America with marketing authorisation for meropenem from Venezuela
US FDA approves ofatumumab
Ofatumumab in combination with chlorambucil is effective for the treatment of previously untreated patients with chronic…
GAVI Alliance plans drive for access to vaccines
Drive to secure a healthy future for children in developing countries
IPM grows 3.9 per cent in March 2014, clocks Rs 5948 crores
10 therapies have outgrown the IPM growth and two therapies have double digit growths